• P. N. Patsalos


Oxcarbazepine (Fig. 1) corresponds chemically to10,11-dihydro-10-oxo-5H-dibenz(b,f)azepine-4-carboxamide with an empirical formula of C15H12N2O2 and a molecular weight of 252.27.


Valproic Acid Active Metabolite Therapeutic Drug Monitoring Pharmacokinetic Interaction Extensive Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1. 
    McKee PJW, Blacklaw J, Forrest G, Gillham RA, Walker SM, Connelly D, Brodie MJ. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol. 1994;37:27–32.PubMedCrossRefGoogle Scholar
  2. 2. 
    Arnoldussen W, Hulsman J, Rentmeester T. The interaction of valproate and clobazam on the metabolism of oxcarbazepine. Epilepsia. 1993;34 (Suppl 2):160.Google Scholar
  3. 3. 
    Hulsman JARJ, Rentmeester TW, Banfield CR, Reidenberg P, Colucci RD, Meehan JW, Radwanski E, Mojavarian P, Lin CC, Nezamis J, Affrime MB, Glue P. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. Clin Pharmacol Ther. 1995;58:383–9.PubMedCrossRefGoogle Scholar
  4. 4. 
    Halasz P, Kalviainen R, Mazurkiewicz-Beldzinska M, Rosenow F, Doty P, Hebert D, Sullivan T. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia. 2009;50:443–53.PubMedCrossRefGoogle Scholar
  5. 5. 
    Novy J, Patsalos PN, Sander JW, Sisodiya SM. Lacosamide neurotoxicity associated with concomitant use of sodium-blocking antiepileptic drugs: a pharmacodynamic interaction? Epilepsy Behav. 2011;20:20–3.PubMedCrossRefGoogle Scholar
  6. 6. 
    Armijo JA, Vega-Gil N, Shushtarian M, Adin J, Herranz JL. 10-Hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio. Influence of age and concomitant antiepileptic drugs. Ther Drug Monit. 2005;27:199–204.PubMedCrossRefGoogle Scholar
  7. 7. 
    Tartara A, Galimberti CA, Manni R, Morino R, Limido G, Gatti G, Bartoli A, Strada G, Perucca E. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbital and valproic acid. Br J Clin Pharmacol. 1993;36:366–8.PubMedCrossRefGoogle Scholar
  8. 8. 
    May TW, Rambeck B, Salke-Kellermann A. Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients. Acta Neurol Scand. 1996;93:393–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • P. N. Patsalos
    • 1
    • 2
  1. 1.UCL-Institute of Neurology Department of Clinical and Experimental EpilepsyLondonLondon
  2. 2.Epilepsy Society Chalfont Centre for EpilepsyBuckinghamshireUK

Personalised recommendations